Medistim ASA · OSL:MEDI

Medistim ASA — Q1 2014 Earnings Presentation

18 slides from Medistim ASA's earnings presentation, Apr 25, 2014

  1. Slide 1: Medistim ASA First Quarter 2014

    Medistim ASA First Quarter 2014 Kari E. Krogstad, President and CEO Thomas Jakobsen, CFO April 25th, 2014

  2. Slide 2: Disclaimer

    2 25.04.2014 Medistim ASA Q1 2014 Disclaimer The information included in this Presentation contains certain forward-looking statements that address activities, events or developments that Medistim ASA (“the Company”) expects, projects, believes or anticipates will or may occur in the future. These s

  3. Slide 3: Table of contents

    3 25.04.2014 Medistim ASA Q1 2014 Table of contents 1. Highlights First Quarter 2. Financial Statements 3. Business Segments Update 4. Implementing the Strategy

  4. Slide 4: 1. Highlights first quarter

    MED (STIM ights first quarter ighl 1. H

  5. Slide 5: Highlights first quarter 2014

    5 25.04.2014 Medistim ASA Q1 2014 Highlights first quarter 2014 • Revenue up 7.4 % Q1 2014 QoQ o Strong development in the imaging business, 67 % growth in VeriQ C capital Revenue 7.4% sales MNOK 48.9 (45.5) o Strong growth in sales of own products in Europe, up 31.9 % o Lack of capital sales explai

  6. Slide 6: 2. Financial statements

    2. Financial statements

  7. Slide 7: Profit and loss Q1 2014

    7 25.04.2014 Medistim ASA Q1 2014 Profit and loss Q1 2014 Profit & loss Q1 2014 Q1 2013 Sales per Quarter (TNOK) All numb ers in NOK 1000 Sales 48 857 45 507 55 000 Cost of goods sold 12 982 12 191 50 000 Salary and sosial expenses 16 775 15 144 45 000 Other operating expenses 9 843 9 071 Total oper

  8. Slide 8: Balance sheet - Assets

    8 25.04.2014 Medistim ASA Q1 2014 Balance sheet - Assets Balance sheet 31.03.2014 31.12.2013 All numb ers in NOK 1000 200 000 Assets 150 000 Intangible assets 50 718 49 399 100 000 Fixed assets 13 542 14 061 50 000 Total intangible and fixed assets 64 260 63 460 - Inventory 38 813 37 930 Q1 13 Q2 13

  9. Slide 9: Balance sheet - Equity and liability

    9 25.04.2014 Medistim ASA Q1 2014 Balance sheet - Equity and liability Balance sheet 31.03.2014 31.12.2013 200 000 All numbers in NOK 1000 150 000 Share capital 4 585 4 585 Premium fund 41 852 41 852 100 000 Other equity 80 274 75 198 50 000 Total equity 126 711 121 635 - Total long term debt 6 745

  10. Slide 10: 3. Business segments update

    3. Business segments update

  11. Slide 11: Flow probes and VeriQ sales in units

    11 25.04.2014 Medistim ASA Q1 2014 Flow probes and VeriQ sales in units Flow probes in units VeriQ systems in units 1 600 35 1 500 30 1 400 25 20 US 1 300 ROW 15 1 200 Europe 10 Asia 1 100 5 0 1 000 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 11 12 12 12 12 13 13 13 13 14 11 12 12 12

  12. Slide 12: Imaging probes and VeriQ C sales in units

    12 25.04.2014 Medistim ASA Q1 2014 Imaging probes and VeriQ C sales in units Imaging probes in units VeriQ C systems in units 14 25 12 20 10 15 8 6 10 4 5 2 0 0 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Imaging probes US i

  13. Slide 13: Q1 revenue performance by region

    13 25.04.2014 Medistim ASA Q1 2014 Q1 revenue performance by region Mill NOK Q1 '14 Q1 '13 Q/Q 2013 Europe 31,9 26,7 19,5 % 114,6 USA 10,7 12,8 -16,4 % 45,9 Asia & Jp 4,4 3,6 22,2 % 19,2 ROW 1,9 2,4 -20,8 % 11,3 (MEA, CAN, SA) Total 48,9 45,5 4,9 % 191,0 • In Europe, there was positive development i

  14. Slide 14: Q1 revenue performance by product

    14 25.04.2014 Medistim ASA Q1 2014 Q1 revenue performance by product Mill NOK Q1 '14 Q1 '13 Q/Q 2013 Procedures (USA) 10,4 10,6 -1,9 % 42,9 Flow probes 14,4 12,6 14,3 % 51,1 Flow systems (VeriQ) 4,2 4,1 2,4 % 17,1 Imaging systems (VeriQ C) 3,1 3,2 -3,1 % 13,9 Imaging probes 0,5 0,3 66,7 % 2,7 3rd pa

  15. Slide 15: 4. Implementing the strategy

    4. Implementing the strategy

  16. Slide 16: Game plan USA

    16 25.04.2014 Medistim ASA Q1 2014 USA Game plan USA PERFORMANCE 2013 GAME PLAN 2014 • Sales revenues down by 5.4% for the year and • Transitioning into new leadership total number of procedures was down by 2.2% • Lower number of capital sales (systems and probes) • Organization structure optimizati

  17. Slide 17: Implementation update

    17 25.04.2014 Medistim ASA Q1 2014 USA Implementation update PERFORMANCE Q1 STATUS GAME PLAN IMPEMENTATION • Revenues down by 16.5% • Regaining confidence in winning • Number of procedures down by 5.5% o 11 new accounts, including Barnes Jewish Hospital, o Card-based procedures down by 7.9% St.Louis

  18. Slide 18: Seeing is believing

    18 25.04.2014 Medistim ASA Q1 2014 Seeing is believing

Medistim — Q1 2014 Earnings Presentation on 6ix